Early HPV vaccination boosts completion rates
Early HPV vaccination at age 9 boosts completion rates, reduces disparities, and enhances cancer prevention effort, according to a recent study from Nemours Children's Health.
Food Insecurity and the Dangers of Infant Formula Dilution
Pediatric RSV vaccine trial enrollment on hold in US, VRBPAC says
The halt follows a severe respiratory disease safety signal observed in a July 2024 phase 1 trial of Moderna's mRNA-1345 and mRNA-1365 vaccine candidates.
Demystifying Infant Formula
COVID-19 Therapy Roundtable: focusing on inpatient care
In this episode, the panel discusses therapies and care around inpatients including mechanical ventilation, extracorporeal membrane oxygenation (ECMO), and remdesivir.
Leniolisib: positive phase 3 data in children aged 4 to 11 years with APDS
Pharming Group N.V. plans to include these findings in worldwide regulatory filings in 2025.
